These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16638682

  • 1. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride.
    Mundada AS, Shrikhande BK.
    Drug Dev Ind Pharm; 2006 Apr; 32(4):443-8. PubMed ID: 16638682
    [Abstract] [Full Text] [Related]

  • 2. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert.
    Mundada AS, Shrikhande BK.
    Curr Eye Res; 2008 May; 33(5):469-75. PubMed ID: 18568884
    [Abstract] [Full Text] [Related]

  • 3. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
    Patel UL, Chotai NP, Nagda CD.
    Pharm Dev Technol; 2012 May; 17(1):15-22. PubMed ID: 20649410
    [Abstract] [Full Text] [Related]

  • 4. Design and evaluation of polymeric ocular drug delivery system.
    Gorle AP, Gattani SG.
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):914-9. PubMed ID: 19721251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development and evaluation of ocular drug delivery system.
    Gorle AP, Gattani SG.
    Pharm Dev Technol; 2010 Sep; 15(1):46-52. PubMed ID: 19552545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits.
    Abdelkader H, Mansour HF.
    Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Formulation and evaluation of controlled-release matrix systems of ciprofloxacin.
    Malipeddi VR, Awasthi R, Dua K.
    Polim Med; 2017 Jun; 47(2):101-106. PubMed ID: 30009587
    [Abstract] [Full Text] [Related]

  • 16. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride.
    Kusum Devi V, Saisivam S, Maria GR, Deepti PU.
    Drug Dev Ind Pharm; 2003 May; 29(5):495-503. PubMed ID: 12779279
    [Abstract] [Full Text] [Related]

  • 17. Long acting betaxolol ocular inserts based on polymer composite.
    Gevariya HB, Patel JK.
    Curr Drug Deliv; 2013 Aug; 10(4):384-93. PubMed ID: 23909665
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Controlled release polymeric ocular delivery of acyclovir.
    Deshpande PB, Dandagi P, Udupa N, Gopal SV, Jain SS, Vasanth SG.
    Pharm Dev Technol; 2010 Aug; 15(4):369-78. PubMed ID: 19772377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.